2004 Annual Meeting | Poster Session 02

Date Tuesday 04/27/04

Time 03:00 PM - 07:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging and Dementia, MS and Related Diseases, Movement Disorders, Epilepsy, Anterior Horn and Peripheral Nerve, Cerebrovascular Disease and Interventional Neurology, Headache and Pain, Behavioral Neurology, Muscle Disease/Neuromuscular Junction

CME Available No CME available

Event Timeline
03:00 PM - 07:00 PM	Abstract	001 - Decreased Nurr1 mRNA in Peripheral Blood Lymphocytes in Parkinson"s Disease
03:00 PM - 07:00 PM	Abstract	002 - Nitric Oxide Donors Attenuate Dopamine - Induced Apototic Cell Death by Maintaining the Mitochondria Membrane Potential in a Cyclic - GMP Independent Mechanism
03:00 PM - 07:00 PM	Abstract	004 - The Pharmacological and Biological Effects of Pramipexole on Dopamine Transporter
03:00 PM - 07:00 PM	Abstract	007 - Subclass Specificity of Neuronal IgG in Parkinsons Disease
03:00 PM - 07:00 PM	Abstract	008 - Tolerance to Myelin Oligodendrocytic Glycoprotein (MOG): The MOG-Transgenic Mice
03:00 PM - 07:00 PM	Abstract	009 - Secretion of Brain-Derived Neurotrophic Factor (BDNF), Interleukin 10 and Transforming Growth Factor Beta by Glatiramer Acetate Specific T-Cells in the Brain
03:00 PM - 07:00 PM	Abstract	010 - Modified Ordered Peptides for the Treatment of Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	011 - The Axonal Regrowth Inhibitor Nogo-66 Contains Immunogenic Epitopes for Experimental Autoimmune Encephalomyelitis
03:00 PM - 07:00 PM	Abstract	012 - In-Vivo MRI Tracking of Magnetically Labeled Neural Spheres Transplanted in Animal Models of Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	013 - Oral Administration of Bowman-Birk Inhibitor Concentrate, a Soybean-Derived Protease Inhibitor, Suppresses EAE in the Lewis Rat: A Potential Oral Therapy for Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	014 - The Orally Active Immunomodulator Laquinimod Inhibits Development of Murine Experimental Autoimmune Encephalomyelitis (EAE) in IFN-[beta]-/- and in Wild Type Mice
03:00 PM - 07:00 PM	Abstract	015 - A New Synthetic Glycolipid OCH Suppresses Experimental Autoimmune Encephalomyelitis (EAE) by Inducing Th2 Bias of Natural Killer (NK) T Cells
03:00 PM - 07:00 PM	Abstract	016 - Citicoline Attenuates Brain and Spinal Cord Inflammation in Rat EAE
03:00 PM - 07:00 PM	Abstract	017 - Axon Specific Autoimmunity in the Central Nervous System of Patients with Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	018 - Direct Impact of T Cells on Neurons as Potential Damage Mechanism in Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	019 - Neurotrophic Factors and Clinical Recovery in Relapsing-Remitting Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	020 - Cocultures of Human T Cells and Neurons Reveal Neurotoxic and Neuroprotective T Cell Subtypes
03:00 PM - 07:00 PM	Abstract	021 - Differential Regulation of Costimulatory Molecule Expression by Sex Hormones in Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	022 - Reduction in IFN-[gamma] Producing T Cells during the Postpartum Period in Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	023 - Auto-Reactive Antibodies in Multiple Sclerosis Patients
03:00 PM - 07:00 PM	Abstract	024 - Differential Susceptibility of Human Adult Oligodendrocytes to Injury Mediated by Nitric Oxide and Peroxynitrite
03:00 PM - 07:00 PM	Abstract	025 - Hydroxychloroquine: A Novel Microglia Modulator?
03:00 PM - 07:00 PM	Abstract	026 - Oxcarbazepine (Trileptal[reg]) Shows Good Safety and Tolerability Profiles over 6 Months in Infants and Very Young Children with Partial Epilepsy
03:00 PM - 07:00 PM	Abstract	027 - Extended-Release Carbamazepine vs. Oxcarbazepine: Computer Simulations of the Effect of Missed Doses on Drug Plasma Levels
03:00 PM - 07:00 PM	Abstract	028 - Levetiracetam Levels in Human Cerebrospinal Fluid: A Controlled, Dose Ranging Pharmacokinetic Study
03:00 PM - 07:00 PM	Abstract	029 - Aromatase Inhibitors as Add-on Treatment for Men with Epilepsy
03:00 PM - 07:00 PM	Abstract	030 - Levtiracetam in Orthotopic Liver Transplantation: Demonstrating Anti-Seizure Efficacy and Reduced Dose of Anti-Rejection Medications in a Complex Patient Population
03:00 PM - 07:00 PM	Abstract	031 - Long-Term Zonisamide Therapy Does Not Cause Tachyphylaxis
03:00 PM - 07:00 PM	Abstract	032 - Inflammatory Modulation of Epileptic Phenomenon in Genetically Epileptic El Mice
03:00 PM - 07:00 PM	Abstract	033 - Automated Seixure Warning System Performance in Temporal Lobe Epilepsy
03:00 PM - 07:00 PM	Abstract	034 - Brain-Derived Neurotrophic Factor and Tyrosine Kinase B Expression in Human Hippocampal Sclerosis: Implications in Epileptogenesis
03:00 PM - 07:00 PM	Abstract	035 - Neocortical Gliosis in Temporal Lobe Epilepsy: Gender Based Differences
03:00 PM - 07:00 PM	Abstract	036 - Cotton-Wool Plaques in Familial and Sporadic Alzheimer's Disease: Distinctive Pathology Reflects Differing Etiologies
03:00 PM - 07:00 PM	Abstract	037 - A Patient without Tau Protein in her Cerebrospinal Fluid
03:00 PM - 07:00 PM	Abstract	038 - A Re-Examination of Alpha-Synuclein Pathology in Alzheimer's Disease with a Presenilin 1 or 2 Mutation
03:00 PM - 07:00 PM	Abstract	039 - Estrogen Metabolizing Gene Comt Polymorphism Synergistic Apolipoprotein E [epsilon]4 Allele Increase the Risk of Alzheimer Disease
03:00 PM - 07:00 PM	Abstract	040 - Naturally Occurring Antibodies Against Unphosphorylated and Phosphorylated Tau in the Sera of Patients Affected by Alzheimer's Disease and in Healthy Subjects
03:00 PM - 07:00 PM	Abstract	041 - Antioxidant Therapy Can Reverse Increased Plasma Susceptibility to Oxidative Stress in Alzheimer Patients
03:00 PM - 07:00 PM	Abstract	042 - Biological Role of Cystatin C in Mild Cognitive Impairment (MCI) and Dementia
03:00 PM - 07:00 PM	Abstract	043 - Mapping Apathy in Alzheimer's Disease: A Structural MRI Study
03:00 PM - 07:00 PM	Abstract	044 - Matrix Metalloproteinase Activity Is Increased in Brain Regions with Alzheimer"s Disease Pathology
03:00 PM - 07:00 PM	Abstract	045 - Mutant Ubiquitin Found in Alzheimer's Disease Causes Mitochondrial Jam in Neurites and Neuronal Degeneration
03:00 PM - 07:00 PM	Abstract	046 - APOE-Dependent PET Patterns of Brain Activation in Alzheimer"s Disease
03:00 PM - 07:00 PM	Abstract	047 - Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy: An FDG-PET Study
03:00 PM - 07:00 PM	Abstract	048 - Diffusion Tensor Imaging of the Fornix in Alzheimer's Disease
03:00 PM - 07:00 PM	Abstract	049 - Screening for Falls, Stroke or Dementia Risk Factors in a Self- Referral, Middle Age Population: Is It Worth the Effort?
03:00 PM - 07:00 PM	Abstract	050 - Reversible Dementia. A Case of Cryptococcal Meningitis Masquerading as Alzheimer's Disease
03:00 PM - 07:00 PM	Abstract	051 - Alzheimer and Cerebrovascular Neuropathology Correlates of Memory and Executive Function
03:00 PM - 07:00 PM	Abstract	052 - The Mindstreams MCI Score: A Practical Clinical Tool for Early Detection of Dementia
03:00 PM - 07:00 PM	Abstract	053 - SGS742, a Novel GABAB Receptor Antagonist, Improves Cognition in Patients with Mild Cognitive Impairment
03:00 PM - 07:00 PM	Abstract	054 - Hippocampal Sclerosis: Cognitive Consequences and Contributions to Dementia
03:00 PM - 07:00 PM	Abstract	055 - Deficits in Executive Function in Idiopathic Elderly Fallers: Association with Fall Risk
03:00 PM - 07:00 PM	Abstract	056 - Ethnicity and Subtypes of Mild Cognitive Impairment
03:00 PM - 07:00 PM	Abstract	057 - Effects of Testosterone on Cognition and Mood in Male Patients with Mild Alzheimer"s Disease and Normal Volunteers
03:00 PM - 07:00 PM	Abstract	058 - Randomized Controlled Trial of Exercise and Yoga in Healthy Seniors
03:00 PM - 07:00 PM	Abstract	059 - Combined Biomarkers in Discriminating Nondemented Aging from Early Alzheimer Disease
03:00 PM - 07:00 PM	Abstract	060 - Screening for Cognitive-Impairment-No-Dementia (CIND): The Predictive Utility of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
03:00 PM - 07:00 PM	Abstract	061 - Stroke, Cerebral Atherosclerosis, and Alzheimer"s Disease
03:00 PM - 07:00 PM	Abstract	062 - Short Version of the Severe Impairment Battery (SIB)
03:00 PM - 07:00 PM	Abstract	063 - The Montreal Cognitive Assessment (MoCA): A Brief Cognitive Screening Tool for Detection of Mild Cognitive Impairment
03:00 PM - 07:00 PM	Abstract	064 - Assessment of Decision Making Capacity in Persons with Mild-Moderate Dementia
03:00 PM - 07:00 PM	Abstract	065 - Cognitive Complaints in Patients with Mild Cognitive Impairment: The PRE-AL Study
03:00 PM - 07:00 PM	Abstract	066 - Phenotype-Genotype Description of Kennedy Disease: Study of 32 French Patients
03:00 PM - 07:00 PM	Abstract	067 - Prospective Study of the Disease Course of Sporadic Adult-Onset Lower Motor Neuron Disease
03:00 PM - 07:00 PM	Abstract	068 - Bayesian Diagnosis of Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM	Abstract	069 - Validation of Telephonic Administration of the ALSFRS-R
03:00 PM - 07:00 PM	Abstract	070 - ALSFRS Predicts Survival and Measures Disease Progression in ALS
03:00 PM - 07:00 PM	Abstract	071 - A Snip (Sniff Nasal Inspiratory Pressure) of Less Than 40cm Predicts Mortality in Patients with Amyotrophic Lateral Sclerosis
03:00 PM - 07:00 PM	Abstract	072 - A Longitudinal Assessment of Caloric Needs in ALS
03:00 PM - 07:00 PM	Abstract	073 - Validation of Energy Requirement Equations Using Doubly Labeled Water in ALS
03:00 PM - 07:00 PM	Abstract	074 - Parotid Gland Injections of Botulinum A Toxin for Refractory Sialorrhea in Patients with Amyotrophic Lateral Sclerosis- A Pilot Study
03:00 PM - 07:00 PM	Abstract	075 - Venous Thrombosis in an ALS Population over Four Years
03:00 PM - 07:00 PM	Abstract	076 - Comparison of Quality of Life, Cognition, and Capacity in Ventilator Dependent and Non-Ventilator Dependent Amyotrophic Lateral Sclerosis Patients
03:00 PM - 07:00 PM	Abstract	077 - A Dynamic Computed Tomographic Study of Cerebral Perfusion Parameters in Acute Middle Cerebral Artery Territory Ischemic Infarction
03:00 PM - 07:00 PM	Abstract	078 - Clinical Presentation and Etiology of Lacunar Infarction Identified by Diffusion-Weighted Magnetic Resonance Imaging
03:00 PM - 07:00 PM	Abstract	079 - Relative Usefulness of CT, MRI, CUS, TEE and TCD in Subacute Stroke Assessment
03:00 PM - 07:00 PM	Abstract	080 - Is White Matter Disease in Ischemic Stroke Patients a Single Pathophysiological Entity ?
03:00 PM - 07:00 PM	Abstract	081 - Degree of Carotid Artery Stenosis and Potential Eligibility for Intervention: The Northern Manhattan Stroke Study
03:00 PM - 07:00 PM	Abstract	082 - Smoking Significantly Increases the Risk of Asymptomatic Carotid Stenosis in Patients Who Have Peripheral Vascular Disease
03:00 PM - 07:00 PM	Abstract	083 - Enzyme Replacement Therapy Improves Cerebral Autoregulation in Fabry Disease
03:00 PM - 07:00 PM	Abstract	084 - Increased Frequency of Dilated Perivascular Spaces in CADASIL
03:00 PM - 07:00 PM	Abstract	085 - Prestroke Cognitive Impairment in Stroke Associated with Small Vessel Disease
03:00 PM - 07:00 PM	Abstract	086 - Right Atrial Flow Dynamics in Symptomatic PFO Patients Compared to Normals Using Cardiac MRI
03:00 PM - 07:00 PM	Abstract	087 - Myocardial Injury in Ischemic Stroke Involving the Insular Cortex
03:00 PM - 07:00 PM	Abstract	088 - Acute Autonomic Dysfunction (AD) Contralateral to Stroke : A Prospective Study of 100 Consecutive Cases
03:00 PM - 07:00 PM	Abstract	089 - Cardiac Injury and Dysfunction Is Associated with Poor Neurological Status after Subarachnoid Hemorrhage
03:00 PM - 07:00 PM	Abstract	091 - Heart Rate Dynamics Predict Post-Stroke Mortality
03:00 PM - 07:00 PM	Abstract	092 - Intracranial Atherosclerosis in African Americans with Ischemic Heart Disease
03:00 PM - 07:00 PM	Abstract	093 - A Model of Diabetic Cerebral White Matter Disease in Mice: Neuroimaging, Histology and Linkage to RAGE Expression
03:00 PM - 07:00 PM	Abstract	094 - Reproducible Model of Cortical and Subcortical Focal Ischemia, in the Nonhuman Primate
03:00 PM - 07:00 PM	Abstract	095 - Overproduction of Nitric Oxide from Neuronal Nitric Oxide Synthase during Ischemia Is Partly Mediated Via Activation of Neuropeptide Y Y1 Receptors
03:00 PM - 07:00 PM	Abstract	096 - Safety of Topiramate in Migraine Prevention: Pooled Results from over 1500 Patients
03:00 PM - 07:00 PM	Abstract	097 - Efficacy of Topiramate in Migraine: MIDAS Scores and Response to Triptans
03:00 PM - 07:00 PM	Abstract	098 - Characterization and Time Course of Paresthesia Associated with Topiramate: Data from Double-Blind, Placebo-Controlled Studies of Topiramate in Migraine Prevention
03:00 PM - 07:00 PM	Abstract	099 - Real-World Experience with Topiramate in the Preventive Treatment of Migraine and Chronic Migraine: Results from a Tertiary Center
03:00 PM - 07:00 PM	Abstract	100 - Evaluation of Early Onset of Response for Topiramate When Used to Prevent Migraines
03:00 PM - 07:00 PM	Abstract	101 - Efficacy of Topiramate in the Treatment of Chronic Daily Headache in Children and Adolescents
03:00 PM - 07:00 PM	Abstract	102 - Topiramate for Migraine Prevention in Adolescent Patients
03:00 PM - 07:00 PM	Abstract	103 - Levetiracetam in the Preventive Treatment of Transformed Migraine. A Prospective Study
03:00 PM - 07:00 PM	Abstract	104 - Polytherapy in Migraine and Chronic Migraine Prevention. Clinical Experience with the Combination of a Beta-Blocker Plus a Tricyclic Antidepressant Plus a Calcium Channel Blocker
03:00 PM - 07:00 PM	Abstract	105 - Botulinum-A Toxin Is Effective and Safe in the Treatment of Ultra-Short-Lasting Headaches and Trigeminal Neuralgias
03:00 PM - 07:00 PM	Abstract	106 - Physician-Diagnosed or Self-Described Tension/Stress Headache: An Evaluation of Migraine Diagnoses and Response to Sumatriptan
03:00 PM - 07:00 PM	Abstract	107 - Sumatriptan 6 mg Subcutaneous as a Successful Treatment for Migraine Associated with Allodynia
03:00 PM - 07:00 PM	Abstract	108 - Sumatriptan 6 mg Subcutaneous as an Effective Migraine Treatment in Patients Who Historically Fail To Respond to Oral Triptans
03:00 PM - 07:00 PM	Abstract	109 - Low Dose Sumatriptan Injection in Injection-Na[iuml]ve Migraineurs
03:00 PM - 07:00 PM	Abstract	110 - Reduction in Productive Time Lost from Work and Non-Work Activities after Migraine Treatment with a New Fast Disintegrating/Rapid Release Formulation of Sumatriptan
03:00 PM - 07:00 PM	Abstract	111 - Intranasal Zolmitriptan 5 mg Is Well Tolerated and Effective during Long-Term Use for the Acute Treatment of Multiple Migraine Attacks
03:00 PM - 07:00 PM	Abstract	112 - High Levels of Satisfaction in Patients Treating Migraine with Zolmitriptan Nasal Spray in a Real Life Setting: Results from Phase 2 of the REALIZE Study
03:00 PM - 07:00 PM	Abstract	113 - A Double-Blind, Randomized, Parallel-Group Trial of Almotriptan 12.5 mg vs Placebo in Migraine Patients Who Respond Poorly to Sumatriptan 50 mg
03:00 PM - 07:00 PM	Abstract	114 - Real World Experience Comparing Neurologist and Primary Care Physician Management of Acute Migraine with Almotriptan in Spain
03:00 PM - 07:00 PM	Abstract	115 - Comparison of Intravenous Valproic Acid with Intravenous Lysine-Acetylsalicylic Acid in Acute Migraine Attacks
03:00 PM - 07:00 PM	Abstract	116 - The OPTimization of Interferon for MS (OPTIMS) Study. A Multicenter Trial Comparing Two Different Doses (250 and 375 mcg) of IFN beta-1b
03:00 PM - 07:00 PM	Abstract	117 - Comparison of the Bioavailability of IV Methylprednisolone and Oral Prednisone in People with Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	118 - Long-Term Observational Follow-Up of the PRISMS Cohort: Analyses of MRI BOD Shows Benefit of High Dose, High-Frequency IFN beta-1a (Rebif[reg])
03:00 PM - 07:00 PM	Abstract	119 - Fludarabine Adjunct Therapy in Interferon-[beta]-Treated Relapsing-Remitting Multiple Sclerosis Patients Experiencing Break through Disease
03:00 PM - 07:00 PM	Abstract	120 - A Case Report: Histopathology of MS Lesions after High-Dose Chemotherapy and Haematopoietic Stem Cell Rescue
03:00 PM - 07:00 PM	Abstract	121 - Treatment of Severe Refractory Optic Neuritis in MS Patients with Intravenous Immunoglobulin
03:00 PM - 07:00 PM	Abstract	122 - A Comparison of the Efficacy and Tolerability of Interferon Beta (IFN[beta]) Products Used as Initial or Follow-Up Therapy for the Treatment of Relapsing Multiple Sclerosis: Results from the QUASIMS Study
03:00 PM - 07:00 PM	Abstract	123 - Combination Therapy (Provigil[reg] + Avonex[reg]) in the Treatment of Attention Problems in Patients with Relapsing-Remitting MS
03:00 PM - 07:00 PM	Abstract	124 - The Persistence of Neutralizing Antibodies to Interferon Beta (IFN[beta]) over 6 Years of Treatment in MS Patients Is Dependent on Titer and IFN[beta] Product
03:00 PM - 07:00 PM	Abstract	125 - Neutralizing Antibodies Reduce the Clinical Efficacy of Interferon Beta Products in Patients with Multiple Sclerosis
03:00 PM - 07:00 PM	Abstract	126 - Prevalence of Pathologic Subtypes of Frontotemporal Dementia, Progressive Supranuclear Palsy, and Corticobasal Degeneration in the Florida Brain Bank Series
03:00 PM - 07:00 PM	Abstract	127 - Heterozygosity at Codon 129 of the Prion Protein Gene (PRNP) Is Over-Represented in Primary Progressive Aphasia
03:00 PM - 07:00 PM	Abstract	128 - Reduced Survival in Frontotemporal Lobar Degeneration
03:00 PM - 07:00 PM	Abstract	129 - Comparison of Clinical Phenotype of Two Families with Hereditary Dysphasic Disinhibition Dementia (HDDD1 and HDDD2)
03:00 PM - 07:00 PM	Abstract	130 - The Reversibility of Dementia in Normal Pressure Hydrocephalus: What Is Reversible and in How Many Patients?
03:00 PM - 07:00 PM	Abstract	131 - The Clinical Profile of Right Temporal Lobe Atrophy
03:00 PM - 07:00 PM	Abstract	132 - Relationship between Major Depression and Lewy Bodies in Alzheimer's Disease
03:00 PM - 07:00 PM	Abstract	133 - Neuropathologic Determinants of Dementia Severity in Lewy Body Variant
03:00 PM - 07:00 PM	Abstract	134 - Longitudinal Study of the Frontal Behavioral Inventory in FTD and PPA
03:00 PM - 07:00 PM	Abstract	135 - Demographic Features of 225 FTLD Patients: U.S. and German Cohort Study
03:00 PM - 07:00 PM	Abstract	137 - Gait Variability in Older Adults with Age-Associated Cognitive Decline
03:00 PM - 07:00 PM	Abstract	138 - The Forward Model in Reaching: Evidence from a Patient with Central Deafferentation
03:00 PM - 07:00 PM	Abstract	139 - Executive Function, Mental Loading and Gait Variability in Parkinson's Disease
03:00 PM - 07:00 PM	Abstract	140 - Kinesthesic Supernumerary Phantom Limb after Pure Subcortical Infarct
03:00 PM - 07:00 PM	Abstract	141 - Novel Control of Tics, Mood, and Creativity with Internal Capsule and Nucleus Accumbens Stimulation
03:00 PM - 07:00 PM	Abstract	142 - Neurocognitive Predictors of Swallowing Recovery in Stroke
03:00 PM - 07:00 PM	Abstract	143 - Only Spontaneous Counterfactual Thinking Is Impaired in Patients with Frontal Lobe Lesions
03:00 PM - 07:00 PM	Abstract	144 - Neural Basis for Sentence Comprehension in Progressive Non-Fluent Aphasia
03:00 PM - 07:00 PM	Abstract	145 - Language-Related Limitations on Information Processing Speed in Parkinson's Disease: Multiplicative Effects of Speech Rate and Syntactic Complexity
03:00 PM - 07:00 PM	Abstract	146 - Dissociation of Language Abilities in 47,XXY Klinefelter Syndrome
03:00 PM - 07:00 PM	Abstract	147 - Voxel-Based Morphometric Analysis of Verbal Fluency: Executive Function vs. Lexical Content
03:00 PM - 07:00 PM	Abstract	148 - Longitudinal Assessment of Sentence Comprehension in Semantic Dementia and Progressive Nonfluent Aphasia
03:00 PM - 07:00 PM	Abstract	149 - Quantitative Analysis of Paraphasic Errors in Frontotemporal Dementia
03:00 PM - 07:00 PM	Abstract	150 - Serotonergic Therapy for Fluent Aphasia
03:00 PM - 07:00 PM	Abstract	151 - Accessing Semantic Knowledge without Overt Naming: A fMRI Study
03:00 PM - 07:00 PM	Abstract	152 - Neurological Bases of Auditory Processing Disorders
03:00 PM - 07:00 PM	Abstract	153 - Anatomy of Thematic and Locative Relationship Deficits in Asyntactic Comprehension
03:00 PM - 07:00 PM	Abstract	154 - HSP70 Chaperone Machinery in Sporadic-Inclusion-Body Myositis Muscle Fibers
03:00 PM - 07:00 PM	Abstract	155 - Proteasome Abnormalities Participate in the Pathogenesis of Sporadic Inclusion Body Myositis (s-IBM)
03:00 PM - 07:00 PM	Abstract	156 - Gene Expression Profiling in Duchenne Muscular Dystrophy Patients Using Specifically Dedicated Oligonucleotide Microarray
03:00 PM - 07:00 PM	Abstract	157 - Combined Deficiency of Calpain and Dystrophin Mutually Reduce the Severity of Phenotypes?
03:00 PM - 07:00 PM	Abstract	158 - Computerized Hand Grip Myometry Reliably Measures Myotonia and Strength in Myotonic Dystrophy (DM1) and Myotonia Correlates Directly with CTG Repeat Size of the DM1 Gene
03:00 PM - 07:00 PM	Abstract	160 - Muscle-Fiber "Apoptosis-Lente" in Chronic Peripheral Neuropathy Involves the Endoplasmic Reticulum Stress Pathway
03:00 PM - 07:00 PM	Abstract	161 - Rhabdomyolysis: 475 Cases over 9 Years from a Single Hospital
03:00 PM - 07:00 PM	Abstract	162 - Impaired Hippocampal Recruitment during an Episodic Memory Task in Patients with Myotonic Dystrophy
03:00 PM - 07:00 PM	Abstract	163 - Hypoglycosylation of Alpha-Dystroglycan in Patients with Hereditary Inclusion Body Myopathy (HIBM) Due to GNE Mutations

Faculty Disclosures
Magda Tsolaki	No disclosure on file
	No disclosure on file
Salvatore Napoli, MD	Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for biogen. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bristol myers. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for serono. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for eisai. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapeutics. Dr. Napoli has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for vaccine injury.
Charles B. Hall, PhD	No disclosure on file
Mitchell S. Elkind, MD, MS, FAAN	Dr. Elkind has received personal compensation for serving as an employee of American Heart Association. Dr. Elkind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Atria Academy.
Suzanne Powell, MD	Dr. Powell has nothing to disclose.
Fred A. Lado, MD	Dr. Lado has a non-compensated relationship as a Board Member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Lado has a non-compensated relationship as a Officer with National Association of Epilepsy Centers that is relevant to AAN interests or activities.
Erik Uhlmann, MD	Dr. Uhlmann has nothing to disclose.
Robert J. Fox, MD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria Biologica. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for InnoCare Pharma. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Fox has received research support from National Institutes of Health. The institution of Dr. Fox has received research support from National MS Society. Dr. Fox has received publishing royalties from a publication relating to health care.
Jose Ramon Ara, MD	No disclosure on file
Mithri R. Junna, MD	Dr. Junna has nothing to disclose.
Robert Zivadinov, MD, PhD, FAAN	The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Omnicuris. The institution of Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Myrobalan. Dr. Zivadinov has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Zivadinov has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Zivadinov has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Christopher Coffey, PhD, FAAN	Dr. Coffey has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Coffey has received research support from NIH. The institution of Dr. Coffey has received research support from Michael J Fox Foundation.
Vera Bril, MD	Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Powell Mansfield. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Momenta (now J&J). Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunovant. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Bril has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL. Dr. Bril has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Bril has received research support from UCB. The institution of Dr. Bril has received research support from Argenx. The institution of Dr. Bril has received research support from Momenta (now J&J). The institution of Dr. Bril has received research support from Immunovant. The institution of Dr. Bril has received research support from Alexion. The institution of Dr. Bril has received research support from Takeda. The institution of Dr. Bril has received research support from Grifols. The institution of Dr. Bril has received research support from CSL. The institution of Dr. Bril has received research support from Octapharma. The institution of Dr. Bril has received research support from Akcea. The institution of Dr. Bril has received research support from Ionis. The institution of Dr. Bril has received research support from Viela Bio (now Horizon). Dr. Bril has received intellectual property interests from a discovery or technology relating to health care.
Niels Bergsland	Prof. Bergsland has nothing to disclose.
Peter J. Koehler, MD, PhD, FAAN	Dr. Koehler has nothing to disclose.
Sanjeev V. Kothare, MD, FAAN	Dr. Kothare has nothing to disclose.
Hans D. Katzberg, MD, FAAN	An immediate family member of Dr. Katzberg has received personal compensation for serving as an employee of Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz. Dr. Katzberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson and Johnson. Dr. Katzberg has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos Health. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Katzberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX.
John M. Stern, MD, FAAN	Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
Matilde Inglese, MD, PhD	Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Richard B. Lipton, MD, FAAN	Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Dennis N. Bourdette, MD, FAAN	Dr. Bourdette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Magellan Health Care. Dr. Bourdette has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Best Doctor's Inc. Dr. Bourdette has stock in Authobahn Therapeutics. Dr. Bourdette has received intellectual property interests from a discovery or technology relating to health care.
Elan D. Louis, MD, MS, FAAN	Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to AAN interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to AAN interests or activities.
Jamie Grimes, MD	No disclosure on file
Heinz Wiendl, MD, FAAN	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Raed Alroughani, MD, FAAN	Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, AstraZeneca, Novartis, Merck, Roche, Sanofi. Dr. Alroughani has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AstraZeneca, Biogen, Novartis, Merck, Roche, Sanofi.
Vikas Gupta, MD	Dr. Gupta has nothing to disclose.
Romain Marignier, MD, PhD	Dr. Marignier has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALEXION. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROCHE. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Marignier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE.
Michael McDermott	No disclosure on file
Patrick Vermersch	Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Science. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imcyse. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS-Celgene. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ad Scientiam. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Patrick Vermersch has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for La revue des microbiotes. The institution of Patrick Vermersch has received research support from Roche. The institution of Patrick Vermersch has received research support from Sanofi.
Weiyi Gao, MD	Dr. Gao has nothing to disclose.
Joseph S. Kass, MD, JD, FAAN	Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ�� . Dr. Kass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Kass has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple Law Firms . Dr. Kass has received publishing royalties from a publication relating to health care.
Doris Kung, DO, FAAN	Dr. Kung has received personal compensation for serving as an employee of Aquifer. The institution of Dr. Kung has received research support from RxFunction. Dr. Kung has received publishing royalties from a publication relating to health care. Dr. Kung has received personal compensation in the range of $0-$499 for serving as a Workgroup member with NBME. Dr. Kung has received personal compensation in the range of $500-$4,999 for serving as a Editor with Aquifer.
Karen Chen, PhD	No disclosure on file
Ellen Carl, MS	No disclosure on file
M. M. Mesulam, MD, FAAN	Dr. Mesulam has received publishing royalties from a publication relating to health care.
Olivier Beauchet, MD, PhD	No disclosure on file
Iftekhar Ahmed, MD, PC, FAAN	Dr. Ahmed has nothing to disclose.
J. David Avila, MD, FAAN	Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca. Dr. Avila has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
Eric Klawiter, MD, FAAN	Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Galen/Atlantica. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Banner Life Sciences. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Klawiter has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for OM1. Dr. Klawiter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Klawiter has received research support from Biogen. The institution of Dr. Klawiter has received research support from Abbvie. The institution of Dr. Klawiter has received research support from Genentech.
Amer Malik, MD	Dr. Malik has nothing to disclose.
Jeffrey S. Kutcher, MD, FAAN	Dr. Kutcher has nothing to disclose.
Thomas G. Brott, MD, FAAN	Dr. Brott has nothing to disclose.
Aashit K. Shah, MD, FAAN	Dr. Shah has stock in Abbot, Abbivie, Gilead, Johnson and Johnson, Pfizer. The institution of Dr. Shah has received research support from Xenon Pharma.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.
Todd D. Levine, MD	Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Kevin N. Sheth, MD, FAAN	Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ceribell. Dr. Sheth has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Sheth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NControl. Dr. Sheth has received stock or an ownership interest from Astrocyte. Dr. Sheth has received stock or an ownership interest from Alva. The institution of Dr. Sheth has received research support from Biogen. The institution of Dr. Sheth has received research support from Novartis. The institution of Dr. Sheth has received research support from Bard. The institution of Dr. Sheth has received research support from Hyperfine. Dr. Sheth has received intellectual property interests from a discovery or technology relating to health care.
Michael Gurevich	No disclosure on file
Scott E. Kasner, MD, FAAN	Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Kasner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Javelin. Dr. Kasner has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Kasner has received research support from WL Gore. The institution of Dr. Kasner has received research support from DiaMedica. The institution of Dr. Kasner has received research support from Bayer.
Osamu Onodera, MD	Dr. Onodera has nothing to disclose.
Amit Bar-Or, MD, FRCPC	Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Merit E. Cudkowicz, MD, MSC, FAAN	Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for cytokinetics. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for immunitypharm. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for transposon. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quralis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for vectorY. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for inflectis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for novartis. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ono. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for otsuka. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for coya. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ac immune. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for pontifax. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inflectis. Dr. Cudkowicz has received personal compensation in the range of $0-$499 for serving as a Consultant for ab science. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for aclipse. Dr. Cudkowicz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Locust Walk. Dr. Cudkowicz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pasithea. Dr. Cudkowicz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Praxis Precision Medicine. Dr. Cudkowicz has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology . The institution of Dr. Cudkowicz has received research support from NINDS. The institution of Dr. Cudkowicz has received research support from ALSFAC. The institution of Dr. Cudkowicz has received research support from UCB ra. The institution of Dr. Cudkowicz has received research support from Biohaven. The institution of Dr. Cudkowicz has received research support from Clene nanomedicine. The institution of Dr. Cudkowicz has received research support from prilenia. The institution of Dr. Cudkowicz has received research support from ALS one. The institution of Dr. Cudkowicz has received research support from Seelos. The institution of Dr. Cudkowicz has received research support from Calico. The institution of Dr. Cudkowicz has received research support from denali. The institution of Dr. Cudkowicz has received research support from ITB. The institution of Dr. Cudkowicz has received research support from PharmAust. The institution of Dr. Cudkowicz has received research support from woolsley. Dr. Cudkowicz has received research support from lilly. The institution of Dr. Cudkowicz has received research support from J& J. Dr. Cudkowicz has received publishing royalties from a publication relating to health care.
Robert T. Naismith, MD, FAAN	Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squib. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Naismith has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genzyme. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celltrion. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impaact-Bio. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyverna. Dr. Naismith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon. Dr. Naismith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch.
Cedric Annweiler, MD, PhD	No disclosure on file
Robin A. Conwit, MD, FAAN	Dr. Conwit has nothing to disclose.
Robert H. Brown, Jr., MD, DPhil	Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has stock in ApicBio. Dr. Brown has stock in Amylx. Dr. Brown has stock in Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care.
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Masato Kanazawa, MD, FAAN	Dr. Kanazawa has nothing to disclose.
Steven Galetta, MD, FAAN	Dr. Galetta has nothing to disclose.
Chin-Sang Chung, MD, PhD	No disclosure on file
Kaoutar El Hafsi	No disclosure on file
Julie A. Khoury, MD	Dr. Khoury has nothing to disclose.
Gustavo Figueira, MD	No disclosure on file
James B. Leverenz, MD, FAAN	Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Leverenz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Leverenz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai.
Eric J. Sorenson, MD, FAAN	The institution of Dr. Sorenson has received research support from Biogen.
Alasdair Coles, MD, PhD	Dr. Coles has nothing to disclose.
Jennifer R. Molano, MD, FAAN	Dr. Molano has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Massachusetts Medical Society . The institution of Dr. Molano has received research support from National Institutes of Health.
Patrick Cras, MD, PhD	The institution of Dr. Cras has received research support from Belgian Fund for Scientific Research. Dr. Cras has received personal compensation in the range of $0-$499 for serving as a member with National Bioethics Committee.
Melissa J. Nirenberg, MD, PhD, FAAN	The institution of Dr. Nirenberg has received research support from Department of Veterans Affairs,. The institution of Dr. Nirenberg has received research support from National Institutes of Health. Dr. Nirenberg has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with Parkinson's Foundation.
Miguel Chuquilin Arista, MD, FAAN	Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item Writer with ��ɫ��. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Item reviewer with National Board of Medical Examiners. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Southeast regional advisory board with Argenx. Dr. Chuquilin Arista has received personal compensation in the range of $500-$4,999 for serving as a Focus group with Alexion. Dr. Chuquilin Arista has received personal compensation in the range of $0-$499 for serving as a Speaker with Periodic Paralysis Association.
David P. Roeltgen, MD, FAAN	No disclosure on file
Patricio Soares-da-Silva	Patricio Soares-da-Silva has received personal compensation for serving as an employee of Bial - Portela & Cª S.A.. Patricio Soares-da-Silva has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Bial - Portela & Cª S.A..
Corrado Angelini, MD, FAAN	Dr. Angelini has nothing to disclose.
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Angelo Antonini, MD	Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Andrew D. Goodman, MD, FAAN	Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Swan Bio. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IMCYSE. Dr. Goodman has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Pfizer. The institution of Dr. Goodman has received research support from Atara. The institution of Dr. Goodman has received research support from Genzyme. The institution of Dr. Goodman has received research support from EMD-Serono.
Anat Achiron, MD, PhD, FAAN	Dr. Achiron has nothing to disclose.
Bradley F. Boeve, MD, FAAN	Dr. Boeve has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Rainwater Charitable Foundation. The institution of Dr. Boeve has received research support from Alector. The institution of Dr. Boeve has received research support from EIP Pharma. The institution of Dr. Boeve has received research support from Transposon. The institution of Dr. Boeve has received research support from Cognition Therapeutics. Dr. Boeve has received publishing royalties from a publication relating to health care.
William W. Seeley, MD	Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Council. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global Consulting. Dr. Seeley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BridgeBio. Dr. Seeley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Seeley has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lyterian Therapeutics. The institution of Dr. Seeley has received research support from NIH. The institution of Dr. Seeley has received research support from Rainwater Charitable Foundation. The institution of Dr. Seeley has received research support from Bluefield Project to Cure FTD. The institution of Dr. Seeley has received research support from Chan-Zuckerberg Initiative.
Michael Silber, MB, ChB, FAAN	Dr. Silber has received publishing royalties from a publication relating to health care. Dr. Silber has received personal compensation in the range of $500-$4,999 for serving as a Topic writer with UpToDate.
Seward B. Rutkove, MD, FAAN	Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Mikael Cohen	Mikael Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Roche, Merck, Ad scientiam, Novartis, Alexion, BMS.
Christine Lebrun Frenay, MD, FAAN	Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Demetrius M. Maraganore, MD, FAAN	Dr. Maraganore has nothing to disclose.
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Richard S. Bedlack, MD, PhD, FAAN	Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Guidepoint Global. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for New Biotic. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Woolsey Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ITF Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Orphazyme. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AB Scicence. Dr. Bedlack has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for ALS Association. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Adept Field Solutions. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apellis. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Black Swan. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clarivate. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clean. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CM Group. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Corcept. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cytokinetics. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Health Advances. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MJH Healthcare. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maple Health Care. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for National Association of Managed Care Physicians. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Projects in Knowledge. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Shinkei Pharma. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Webb MD/Medscape. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mallinkrodt. Dr. Bedlack has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion . Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurosense. Dr. Bedlack has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amylyx. Dr. Bedlack has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for GenieUS. The institution of Dr. Bedlack has received research support from Cytokinetics. The institution of Dr. Bedlack has received research support from Orion. The institution of Dr. Bedlack has received research support from Ultragenyx. The institution of Dr. Bedlack has received research support from MediciNova. The institution of Dr. Bedlack has received research support from Healey Center. Dr. Bedlack has received publishing royalties from a publication relating to health care.
Steve Chung, MD, FAAN	The institution of Dr. Chung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ucb pharma. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life sciences. Dr. Chung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for eisai. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for ucb. Dr. Chung has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK Life sciences. Dr. Chung has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for sunovion.
Yi-Chung Lee, MD, FAAN	The institution of Dr. Lee has received research support from National Science and technology Council Taiwan . The institution of Dr. Lee has received research support from Taipei Veterans General Hospital Taiwan.
Jouko I. Isojarvi, MD, PhD	No disclosure on file
Emma Ciafaloni, MD, FAAN	Dr. Ciafaloni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx, Alexion, Sarepta, UCB, Hoffman-LaRoche, Biogen. Dr. Ciafaloni has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis, AnnJi Pharmaceutical, ML-BIO, Avidity. The institution of Dr. Ciafaloni has received research support from CDC, CureSMA, FDA, Orphazyme, Sarepta, PCORI, Neurogene. Dr. Ciafaloni has received publishing royalties from a publication relating to health care.
Richard Zweifler, MD, FAAN	No disclosure on file
Deborah E. Barnes, PhD, MPH	The institution of Dr. Barnes has received research support from the National Institutes of Health, Department of Veterans Affairs, Department of Defense, Alzheimer's Association, and the California Department of Public Health.
Lauren A. Beslow, MD	Dr. Beslow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various . The institution of Dr. Beslow has received research support from NIH. Dr. Beslow has received publishing royalties from a publication relating to health care.
Sandipan Pati, MD	Dr. Pati has nothing to disclose.
Giovanni Meola, MD, FAAN	No disclosure on file
Bradford Dickerson, MD, FAAN	Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lantheus. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Dickerson has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arkuda. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Dickerson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Dickerson has received publishing royalties from a publication relating to health care. Dr. Dickerson has received publishing royalties from a publication relating to health care.
Stacey Clardy, MD, PhD, FAAN	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/AAN Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a AAN Summer Meeting CoDirector Travel and Lodging with AAN. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Beaumont Health, CCF, Emory, Penn State, Mayo Clinic, Walter Reed.
Claude J. Desnuelle, MD	No disclosure on file
L D. DeWitt, MD	Dr. DeWitt has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen.
Jagan Pillai, MD, PhD, FAAN	Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Nature. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Treatment Options in Neurology. The institution of Dr. Pillai has received research support from Alzheimer's Association. The institution of Dr. Pillai has received research support from Keep Memory Alive Foundation . The institution of Dr. Pillai has received research support from NIA. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with DOD. Dr. Pillai has received personal compensation in the range of $500-$4,999 for serving as a Reviewer with RGC Hong kong.
John H. Sladky, MD, FAAN	Dr. Sladky has nothing to disclose.
Anne Louise Oaklander, MD, PhD, FAAN	The institution of Dr. Oaklander has received research support from National Institutes of Health.
Tetsuya Takahashi, PhD	No disclosure on file
Jean Pelletier, MD, PhD	Dr. Pelletier has nothing to disclose.
Edward Fox, MD, PhD, FAAN	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Marwan N. Sabbagh, MD, FAAN	Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Jeffrey A. Cohen, MD	Dr. Cohen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Convelo. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astoria. Dr. Cohen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSI. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Cohen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celltrion.
Robert A. Bermel, MD, FAAN	Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Bermel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Bermel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Bermel has received research support from Biogen. The institution of Dr. Bermel has received research support from Roche. The institution of Dr. Bermel has received research support from Novartis. Dr. Bermel has received intellectual property interests from a discovery or technology relating to health care.
Basil Sharrack, MD, PhD, FAAN	Dr. Sharrack has nothing to disclose.
Michael Chez, MD, FAAN	Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for marinus. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelsi. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ucb. Dr. Chez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst.
Alejandro L. Escalaya, MD	Dr. Escalaya has nothing to disclose.
Hans-Peter Hartung, MD, FAAN	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Benedetta Nacmias	Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Lyell K. Jones, MD, FAAN	Dr. Jones has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. Dr. Jones has received publishing royalties from a publication relating to health care. Dr. Jones has received personal compensation in the range of $10,000-$49,999 for serving as a President-Elect with ��ɫ��. Dr. Jones has a non-compensated relationship as a member of the AAN Board of Directors with AAN that is relevant to AAN interests or activities. Dr. Jones has a non-compensated relationship as a Chair of the Mayo Clinic ACO Board of Directors with Mayo Clinic that is relevant to AAN interests or activities.
Nancy L. Kuntz, MD, FAAN	Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Vanda Lennon, MD, PhD	The institution of Dr. Lennon has received research support from NIH. Dr. Lennon has received intellectual property interests from a discovery or technology relating to health care.
Jayawant N. Mandrekar, PhD	Dr. Mandrekar has nothing to disclose.
Steven Shook, MD	Dr. Shook has nothing to disclose.
Kristine Yaffe, MD	Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Yaffe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quintiles. Dr. Yaffe has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Alector. The institution of Dr. Yaffe has received research support from NIH. The institution of Dr. Yaffe has received research support from DOD. The institution of Dr. Yaffe has received research support from Veterans Affairs.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Alberto Lleo, MD	Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lleo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Lleo has received research support from Instituto de Salud Carlos III. The institution of Dr. Lleo has received research support from Generalitat de Calalunya (PERIS). The institution of Dr. Lleo has received research support from BBVA Foundation. The institution of Dr. Lleo has received research support from La Caixa Foundation. Dr. Lleo has received intellectual property interests from a discovery or technology relating to health care.
Sandro Sorbi	Sandro Sorbi has nothing to disclose.
Michele Mass, MD	No disclosure on file
David C. Preston, MD, FAAN	Dr. Preston has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for FBI, US Attorney, Insurance Fraud Investigative Units. Dr. Preston has received publishing royalties from a publication relating to health care.
Wim Van Hecke, PhD	Dr. Van Hecke has received personal compensation for serving as an employee of icometrix.
Iram Zaman, DO, FAAN	Dr. Zaman has nothing to disclose.
Monique M. Ryan, MD	Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CSL Behring . Dr. Ryan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Ryan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen . The institution of Dr. Ryan has received research support from Save our Sons Muscular Dystrophy . The institution of Dr. Ryan has received research support from Muscular Dystrophy Australia. Dr. Ryan has received publishing royalties from a publication relating to health care.
Gustavo Saposnik, MD	Dr. Saposnik has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Saposnik has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NIHSS. The institution of Dr. Saposnik has received research support from Roche. The institution of Dr. Saposnik has received research support from Heart and Stroke Foundation of Canada.
Niall Tubridy, MD	Dr. Tubridy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis .
Anthony L. Ritaccio, MD, FAAN	The institution of Dr. Ritaccio has received research support from NIH. Dr. Ritaccio has received intellectual property interests from a discovery or technology relating to health care.
Maja Tippmann-Peikert, MD	Dr. Tippmann-Peikert has nothing to disclose.
Mary Reilly, MD, FRCP, FRCPI	The institution of Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alynlam. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AKCEA. Mary Reilly, MD, FRCP, FRCPI has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inflectis. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MRC. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from NIH. The institution of Mary Reilly, MD, FRCP, FRCPI has received research support from MDA.
Joshua Z. Willey, MD, FAAN	Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Gregory A. Worrell, MD	Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Gerwin Schalk, PhD	No disclosure on file
Takayoshi Shimohata, MD, FAAN	Dr. Shimohata has nothing to disclose.
Najib I. Murr, MD, FAAN	Dr. Murr has nothing to disclose.
Bruce I. Ovbiagele, MD, MSc, FAAN	Dr. Ovbiagele has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Stroke Association. Dr. Ovbiagele has received research support from National Institutes of Health. Dr. Ovbiagele has a non-compensated relationship as a President with Society for Equity Neuroscience that is relevant to AAN interests or activities. Dr. Ovbiagele has a non-compensated relationship as a Board Member with World Stroke Organization that is relevant to AAN interests or activities.
Masatoyo Nishizawa, MD	No disclosure on file
Daniel Ontaneda, MD, PhD, FAAN	Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech/Roche. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen Idec. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Ontaneda has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Ontaneda has received research support from NIH. The institution of Dr. Ontaneda has received research support from PCORI. The institution of Dr. Ontaneda has received research support from NMSS. The institution of Dr. Ontaneda has received research support from Genetech.
John W. Rose, MD, FAAN	The institution of Dr. Rose has received research support from National Multiple Sclerosis Society. The institution of Dr. Rose has received research support from Guthy Jackson Charitable Foundation. The institution of Dr. Rose has received research support from NIH . The institution of Dr. Rose has received research support from VA. The institution of Dr. Rose has received research support from Biogen. The institution of Dr. Rose has received research support from Friends of MS. Dr. Rose has received intellectual property interests from a discovery or technology relating to health care.
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Richard S. Finkel, MD, FAAN	Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AveXis. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ReveraGen. Dr. Finkel has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Finkel has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Finkel has received research support from AveXis. The institution of Dr. Finkel has received research support from Biogen. The institution of Dr. Finkel has received research support from Capricor. The institution of Dr. Finkel has received research support from Catabasis. The institution of Dr. Finkel has received research support from ReveraGen. The institution of Dr. Finkel has received research support from Roche. The institution of Dr. Finkel has received research support from Scholar Rock. Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Finkel has received intellectual property interests from a discovery or technology relating to health care. Dr. Finkel has received personal compensation in the range of $0-$499 for serving as a Speaker in workshop with National Academy of Sciences. Dr. Finkel has a non-compensated relationship as a advisor with n-Lorem Foundation that is relevant to AAN interests or activities. Dr. Finkel has a non-compensated relationship as a Board Member with EveryLife Foundation that is relevant to AAN interests or activities.
Jill L. Ostrem, MD, FAAN	Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz . Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Superness. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AcureX. Dr. Ostrem has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspen. Dr. Ostrem has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders. The institution of Dr. Ostrem has received research support from Neuroderm. The institution of Dr. Ostrem has received research support from Boston Scientific. The institution of Dr. Ostrem has received research support from Medtronic. The institution of Dr. Ostrem has received research support from Rune.
Bing-Wen Soong, MD, PhD, FAAN	No disclosure on file
Galeno Rojas, MD	No disclosure on file
Nizar Souayah, MD, FAAN	Dr. Souayah has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Souayah has received publishing royalties from a publication relating to health care.
Vijayshree Yadav, MD, FAAN	Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen Pharmaceuticals. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb Foundation. Dr. Yadav has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD-Serono . The institution of Dr. Yadav has received research support from Department of Veterans Affairs. Dr. Yadav has received research support from NIH. Dr. Yadav has received research support from PCORI. Dr. Yadav has received research support from NMSS. The institution of Dr. Yadav has received research support from Department of Veterans Affairs. The institution of Dr. Yadav has received research support from Tykeson Family Foundation Endowed Professorship.
Ashutosh P. Jadhav, MD, FAAN	Dr. Jadhav has nothing to disclose.
Kaj Blennow	Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ALZPath. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AriBio. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Beckman-Coulter. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BioArctic. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Moleac Pte. Ltd. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurimmune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ono Pharma. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prothena. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quanterix. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Siemens Healthineers. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Julius Clinical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AC Immune. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celdara Medical. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. Kaj Blennow has received personal compensation in the range of $500-$4,999 for serving as a Co-founder with Brain Biomarker Solutions.
Xin Wang, MD	No disclosure on file
Sarah A. Morrow, MD, MSC, FRCPC, FAAN	Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono/Merck. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Morrow has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SanofiGenzyme. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Morrow has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Morrow has received research support from Celgene. The institution of Dr. Morrow has received research support from SanofiGenzyme. The institution of Dr. Morrow has received research support from Novartis.
Alessandro Padovani, MD	No disclosure on file
Shay Menascu, MD	No disclosure on file
Lonni Schultz, PhD	Dr. Schultz has nothing to disclose.
Huma Sheikh, MD	Dr. Sheikh has nothing to disclose.
Karen A. Schwab	No disclosure on file
Lawrence R. Wechsler, MD, FAAN	Dr. Wechsler has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Neurological Association. Dr. Wechsler has stock in Forest Devices.
Ann Scher, PhD, FAAN	No disclosure on file
Joe Verghese, MD, FAAN	Dr. Verghese has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MedRhythms Inc. The institution of Dr. Verghese has received research support from National Institutes of Health.
Sean J. Pittock, MD, FAAN	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Jawad Bajwa, MD	No disclosure on file
Shree Pandya, DPT	No disclosure on file
Annalena Venneri, PhD	No disclosure on file
Gail H. Marracci, PhD	No disclosure on file
Sarah I. Sheikh, BM Bch, MSc, MRCP, FAAN	Dr. Sheikh has received personal compensation for serving as an employee of Takeda.
James M. Noble, MD, FAAN	Dr. Noble has received stock or an ownership interest from NoMo Diagnostics. The institution of Dr. Noble has received research support from National Institute on Aging.
Sandra Weintraub, PhD, FAAN	Dr. Weintraub has nothing to disclose.
Mustafa S. Siddiqui, MD, FAAN	Dr. Siddiqui has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Boston Scientific Neuromodulation. Dr. Siddiqui has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Dr. Siddiqui has received research support from Boston Scientific Neuromodulation. The institution of Dr. Siddiqui has received research support from Abbvie. The institution of Dr. Siddiqui has received research support from National Institute of Health .
Bianca Weinstock-Guttman, MD	Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
Dileep R. Yavagal, MD, FAAN	Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.
Bashar Katirji, MD, FAAN	Dr. Katirji has nothing to disclose.
Andrew McKeon, MD	The institution of Dr. McKeon has received research support from National Institutes of Health. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received intellectual property interests from a discovery or technology relating to health care. Dr. McKeon has received publishing royalties from a publication relating to health care.
Steven A. Sparr, MD, FAAN	Dr. Sparr has nothing to disclose.
H. E. Hinson, MD, MCR, FAAN	Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. Dr. Hinson has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association.
Peter Brunner	No disclosure on file
Giuliano Binetti, MD	No disclosure on file
Jennifer L. Hopp, MD, FAAN	The institution of Dr. Hopp has received research support from MII TA Grant 20180828 TEDCO EpiWatch: A Mobile Health Application for Epilepsy Management. The institution of Dr. Hopp has received research support from MII TA Grant TEDCO Project #0723-012 EPIScalp; A Novel Tool for Diagnosing Epilepsy from Scalp EEG. The institution of Dr. Hopp has received research support from NIH R44NS137845. Dr. Hopp has received publishing royalties from a publication relating to health care. Dr. Hopp has received personal compensation in the range of $5,000-$9,999 for serving as a Faculty with J. Kiffin Penry Epilepsy ��ɫ��al Programs.
Mi-Ji Lee, MD	Dr. Lee has nothing to disclose.
Wildon Farwell, MD	Dr. Farwell has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Farwell has received personal compensation for serving as an employee of Satellos Biosciences. Dr. Farwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Paragon Therapeutics. Dr. Farwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Farwell has stock in Dyne Therapeutics. Dr. Farwell has stock in Satellos Bioscience.
Stuart S. Mossman, MD	No disclosure on file
Erin M. Feinstein, DO	Dr. Feinstein has nothing to disclose.
Mark Dolev Dolgopiat, MD	No disclosure on file
Erik K. St. Louis, MD	The institution of Dr. St. Louis has received research support from NIH. Dr. St. Louis has received publishing royalties from a publication relating to health care. Dr. St. Louis has received publishing royalties from a publication relating to health care.
Sophie Pittion	Sophie Pittion has nothing to disclose.
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Michael Hossack, MD	Dr. Hossack has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Rivanna.
Divpreet Kaur, MD	No disclosure on file
John A. Morren, MD, FAAN	Dr. Morren has received publishing royalties from a publication relating to health care.
William L. Hills, MD	No disclosure on file
Raquel Sanchez Del Valle Diaz, MD	No disclosure on file
Antonio G. Gallo, MD	No disclosure on file
Angel P. Sempere, MD	Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Sempere has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Mehmet Yaman, MD	No disclosure on file
Robert P. Lisak, MD, FAAN	Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argnex. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Third Bridge Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clearview Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alivar Therapeutics. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ANI Pharmaceuticals. Dr. Lisak has received personal compensation in the range of $0-$499 for serving as a Consultant for Coleman Research. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunic. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Tedus Consulting. Dr. Lisak has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for COUR Pharma. The institution of Dr. Lisak has received research support from NINDS. The institution of Dr. Lisak has received research support from Argenx. The institution of Dr. Lisak has received research support from Ra Pharmaceuticals. Dr. Lisak has received publishing royalties from a publication relating to health care. Dr. Lisak has received publishing royalties from a publication relating to health care.
Adrienne Visani	Ms. Visani has nothing to disclose.
Ashley Finch	No disclosure on file
Brenda Thornell	No disclosure on file
Michael H. Young, MD	No disclosure on file
Gogi Kumar, MD	Dr. Kumar has nothing to disclose.
Kester Phillips, MD	No disclosure on file
Noureldin Abdelhamid, MD	Dr. Abdelhamid has nothing to disclose.
Duarte G. Machado, MD, FAAN	Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Supernus. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merz. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurocrine. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Machado has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva.
Henry Houlden	No disclosure on file
Helen Barkan, MD, PhD	No disclosure on file
Fatima Chreif	No disclosure on file
Theodoros Avramidis	No disclosure on file
Monisha A. Kumar, MD	Dr. Kumar has nothing to disclose.
Madalina Chirieac, MD	No disclosure on file
Jenny Meyer, MD	The institution of Dr. Meyer has received research support from Grifols. The institution of Dr. Meyer has received research support from Medicinova.
Melissa C. Lipford, MD	Dr. Lipford has nothing to disclose.
Takahiko Saida	Takahiko Saida has nothing to disclose.
Jing Ding, MD	No disclosure on file
Ari Breiner, MD	Dr. Breiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma. Dr. Breiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. The institution of Dr. Breiner has received research support from Deparment of Medicine, University of Ottawa.
Eudocia Q. Lee, MD	No disclosure on file
Christopher R. Newey, DO	Dr. Newey has nothing to disclose.
Nicole M. McGrath, MB, CHB	No disclosure on file
Alex Berenstein, MD	No disclosure on file
Arayamparambil Anilkumar, MD, FAAN	Dr. Anilkumar has received publishing royalties from a publication relating to health care.
Daniel Friedman, MD, FAAN	The institution of Dr. Friedman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Epilepsy Study Consortium (non-profit). Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Meili Technology. Dr. Friedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. Dr. Friedman has stock in Neuroview Technology. The institution of Dr. Friedman has received research support from NIH. The institution of Dr. Friedman has received research support from CDC. The institution of Dr. Friedman has received research support from Epitel. The institution of Dr. Friedman has received research support from Neuropace. The institution of Dr. Friedman has received research support from Rapport Therapeutics. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received intellectual property interests from a discovery or technology relating to health care. Dr. Friedman has received publishing royalties from a publication relating to health care. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with SK Life Sciences. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Speaker Honorarium with AAN. Dr. Friedman has received personal compensation in the range of $500-$4,999 for serving as a Travel Reimbursement with Epilepsy Foundation of America.
Panida Piboolnurak, MD	No disclosure on file
Shivam O. Mittal, MD, FAAN	Dr. Mittal has nothing to disclose.
Jessica Deleon, MD	The institution of Dr. Deleon has received research support from NIH.
Malik Adil, MBBS	No disclosure on file
Peter Y. Van Den Bergh, MD, PhD, FAAN	Dr. Van den Bergh has nothing to disclose.
Neha M. Kramer, MD	Dr. Kramer has nothing to disclose.
Saba N. Saeed, MD	No disclosure on file
David S. Roby, MD	No disclosure on file
Otto Appenzeller, MD, PhD	No disclosure on file
Bertrand Audoin	No disclosure on file
Howard W. Sander, MD, FAAN	Dr. Sander has received personal compensation for serving as an employee of Grifols. Dr. Sander has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law firm.
Dixie J. Ecklund, RN	The institution of Ms. Ecklund has received research support from NIH. The institution of Ms. Ecklund has received research support from Michael J. Fox Foundation. Ms. Ecklund has received personal compensation in the range of $500-$4,999 for serving as a Scientific Review Board with Department of Defense. Ms. Ecklund has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Northwestern University.
Sharmila Suri Mohanram, MD	No disclosure on file
Ali Mahta, MD	Dr. Mahta has received research support from Brown University Health.
Hanane Touil, PhD	No disclosure on file
Raquel Gardner, MD	Dr. Gardner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BrainBox. The institution of Dr. Gardner has received research support from NIH. The institution of Dr. Gardner has received research support from DoD.
Joseph S. Chung, DO	No disclosure on file
Chaorui C. Huang, MD	No disclosure on file
Karen P. Frei, MD	The institution of Dr. Frei has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier Clinical Parkinsonism and Related Disorders journal.
Arnold A. Brizuela, MD	No disclosure on file
Lori H. Travis, MD	No disclosure on file
M. F. Beal, MD	No disclosure on file
Maria Petracca, PhD	Dr. Petracca has nothing to disclose.
Lama Al-Khoury, MD	Dr. Al-Khoury has nothing to disclose.
Simon Broadley, PhD, FRACP	The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC.
Lieven G. Lagae, PhD	Dr. Lagae has nothing to disclose.
David Brassat, MD, PhD	No disclosure on file
Ayham M. Alkhachroum, MD	The institution of Dr. Alkhachroum has received research support from Miami CTSI.
Yi-Chu Liao, MD	Dr. Liao has nothing to disclose.
Saurabh R. Sinha, MD, PhD, FAAN	Dr. Sinha has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neumora. Dr. Sinha has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Basilea Inc. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NAMSA. Dr. Sinha has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Clinical Neurophysiology Society. Dr. Sinha has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Clinical and Translational Neurology. Dr. Sinha has received publishing royalties from a publication relating to health care. Dr. Sinha has a non-compensated relationship as a Board Member/Officer with American Clinical Neurophysiology Soceity that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Board Member/Officer with ABRET Lab-LTM Board that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Board Member with American Board of Clinical Neurophysiology that is relevant to AAN interests or activities. Dr. Sinha has a non-compensated relationship as a Committee Member with American Epilepsy Society that is relevant to AAN interests or activities.
Johanna T. Fifi, MD, FAAN	Dr. Fifi has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Stryker, Inc. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerenovus. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Dr. Fifi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Serenity. Dr. Fifi has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MIVI. Dr. Fifi has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. Dr. Fifi has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various law firms. Dr. Fifi has stock in Endostream. Dr. Fifi has stock in Synchron. Dr. Fifi has stock in Imperative Care. Dr. Fifi has stock in Truvic. Dr. Fifi has stock in Bendit. Dr. Fifi has stock in Cerebrotech. Dr. Fifi has stock in Sim&Cure. Dr. Fifi has stock in Q'Apel. The institution of Dr. Fifi has received research support from Viz AI.
Manjamalai Sivaraman, MD	Dr. Sivaraman has nothing to disclose.
Nassim Naderi, MD	No disclosure on file
Jennifer G. Chu, MD	No disclosure on file
Christopher M. Parres, MD	No disclosure on file
Komal Rastogi, MD, FAAN	No disclosure on file
Xue Ming, MD	Dr. Ming has nothing to disclose.
Jeffrey M. Kornitzer, MD, FAAN	Dr. Kornitzer has nothing to disclose.
Navid Jalali, MD	No disclosure on file
Manav Vyas, MD	The institution of Dr. Vyas has received research support from Heart and Stroke Foundation of Canada . The institution of Dr. Vyas has received research support from Canadian Institutes of Health Research . Dr. Vyas has received research support from Heart and Stroke Foundation of Canada .
Nitya Bandla, MD	Dr. Bandla has nothing to disclose.
Jaspreet K. Mann, DO	No disclosure on file
Jie Li	No disclosure on file
Evan A. Jolliffe, MD	No disclosure on file
Yo-Tsen Liu, MD	Dr. Liu has nothing to disclose.
Lan Luo, MD, MS	Dr. Luo has received personal compensation in the range of $0-$499 for serving as a Consultant for Destum Partners. Dr. Luo has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint Global. Dr. Luo has received research support from BIDMC/HMS.
Julia J. Schubert	No disclosure on file
Annemie Ribbens	Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Robert G. Smith, MD, PhD, FAAN	Dr. Smith has nothing to disclose.
Ahmad El Kouzi, MD, FAAN	Dr. El Kouzi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Rohini D. Samudralwar, MD	Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Samudralwar has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Multiple Sclerosis Association of America.
Jonathan Ciron, MD	Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Jonathan Ciron, MD has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS - Celgene. Jonathan Ciron, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Suraj Rajan, MD	No disclosure on file
Eiji Kitamura	Eiji Kitamura has nothing to disclose.
Sankar Bandyopadhyay, MD, FAAN	Dr. Bandyopadhyay has nothing to disclose.
Rabindra Shrestha	No disclosure on file
Stefania Maraka, MD	Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics. Dr. Maraka has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for SpringWorks Therapeutics . The institution of an immediate family member of Dr. Maraka has received research support from Baxter.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Premkumar Nattanmai Chandrasekaran, MD	Dr. Nattanmai Chandrasekaran has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB pharma.
Noah Beadell, MD	No disclosure on file
Stephen C. Cannon, MD	No disclosure on file
David Altschul	No disclosure on file
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Jacob Strand, MD	No disclosure on file
Caitlin A. Massone, MD	No disclosure on file
Kaori Hojo	No disclosure on file
Pei-chien Tsai	No disclosure on file
Monica E. Loghin, MD	Dr. Loghin has nothing to disclose.
Tanzila Kulman, MD	No disclosure on file
David H. Margolin, MD, PhD	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Audrey Rico Lamy	No disclosure on file
Jon Yankey	No disclosure on file
Michael A. De Georgia, MD	Dr. De Georgia has nothing to disclose.
Laura Nist, MD, FAAN	Dr. Nist has nothing to disclose.
Paul Wright, MD, FAAN	Dr. Wright has nothing to disclose.
Rodney D. Bell, MD	Dr. Bell has received publishing royalties from a publication relating to health care.
Alan G. Finkel, MD, FAHS, FAAN	Dr. Finkel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Carolina Headache Foundation. Dr. Finkel has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Various.
Hiroki Takano, MD	No disclosure on file
Carissa Pineda, MD	Dr. Pineda has nothing to disclose.
Cynthia M. Carlsson	The institution of Cynthia M. Carlsson has received research support from NIH/NIA. The institution of Cynthia M. Carlsson has received research support from Department of Veterans Affairs. The institution of Cynthia M. Carlsson has received research support from NIH/Lilly. The institution of Cynthia M. Carlsson has received research support from NIH/NIA. The institution of Cynthia M. Carlsson has received research support from NIH/Eisai. The institution of Cynthia M. Carlsson has received research support from Alzheimer's Association. The institution of Cynthia M. Carlsson has received research support from NIH/NIA. The institution of Cynthia M. Carlsson has received research support from University of Wisconsin Department of Medicine. Cynthia M. Carlsson has received personal compensation in the range of $500-$4,999 for serving as a Study Section Reviewer, Clinical Task Force Member with NIH/NIA. Cynthia M. Carlsson has a non-compensated relationship as a Chair, Advisory Council on Alzheimer's Research, Care, and Services with US Health and Human Services that is relevant to AAN interests or activities.
Anumeha S. Sheth, MBBS	Dr. Sheth has nothing to disclose.
Jeremy Lankford, MD	No disclosure on file
Megha Dhamne, MD	No disclosure on file
Kavit Shah, MD	Dr. Shah has nothing to disclose.
Adam Truong	No disclosure on file
Richard Loeb	No disclosure on file
Valeria A. Sansone, MD	Dr. Sansone has nothing to disclose.
Osman Farooq, MD	Dr. Farooq has nothing to disclose.
Priyank Khandelwal, MD	Dr. Khandelwal has nothing to disclose.
Jafar Kafaie, MD, PhD, FAAN	Dr. Kafaie has nothing to disclose.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Crystal J. Yeo, MD, PhD	Dr. Yeo has nothing to disclose.
Rajesh K. Sadasivuni, MD	No disclosure on file
Jaya Trivedi, MD, FAAN	The institution of Dr. Trivedi has received research support from Avidity.
Sean C. Rose, MD, FAAN	Dr. Rose has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Summit Experts. The institution of Dr. Rose has received research support from Dale Earnhardt Jr Foundation.
Sumul Y. Modi, MD	No disclosure on file
Jessica F. Robb, MD	No disclosure on file
Molly Zimmerman	No disclosure on file
Namir Khandker, MD	No disclosure on file
Muhammad Affan, MD	Dr. Affan has nothing to disclose.
Luisa H. Klotz, MD	Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono. Dr. Klotz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Klotz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris. Dr. Klotz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. The institution of Dr. Klotz has received research support from Immunic AG. The institution of Dr. Klotz has received research support from Merck.
Mill Etienne, MD, MPH, FAAN	Dr. Etienne has nothing to disclose.
David Sandness, MD	Dr. Sandness has nothing to disclose.
Pedro Gonzalez-Alegre, MD	Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Therapeutics. Dr. Gonzalez-Alegre has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NeuExcell. The institution of Dr. Gonzalez-Alegre has received research support from NIH/NINDS. Dr. Gonzalez-Alegre has received intellectual property interests from a discovery or technology relating to health care.
Stephen A. McGuire, MD, FAAN	No disclosure on file
Devanshi Dharaiya, MD	No disclosure on file
Orrin Devinsky, MD, FAAN	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Xiannan Tang, MD, PhD	No disclosure on file
Henrik Zetterberg	Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie, Acumen, Alector, Alzinova, ALZpath, Amylyx, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, LabCorp, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Quanterix, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alzecure, BioArctic, Biogen, Cellectricon, Fujirebio, Lilly, Novo Nordisk, Roche, and WebMD. Henrik Zetterberg has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley and Elsevier. Henrik Zetterberg has stock in Brain Biomarker Solutions.
Brian Crum, MD	Dr. Crum has nothing to disclose.
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to AAN interests or activities.
Amelia K. Boehme, PhD	Dr. Boehme has nothing to disclose.
Hailong Cheng	No disclosure on file
Yehya A. Seddeq, MD	No disclosure on file
Ali K. Al Balushi, MD	No disclosure on file
Sridhara S. Yaddanapudi, MD	Dr. Yaddanapudi has nothing to disclose.
Asaff Harel, MD	Dr. Harel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Harel has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Expert Institute.
Andreas Lysandropoulos	Andreas Lysandropoulos has nothing to disclose.
Purwa Joshi, MBBS	No disclosure on file
M. M. Paz Soldan, MD, PhD	Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Imama A. Naqvi, MD	Dr. Naqvi has nothing to disclose.
Ian J. Butler, MD	No disclosure on file
Julie Van Der Zee	No disclosure on file
Michael L. Lipton, MD, PhD	No disclosure on file
Amy M. Duhig, PhD	No disclosure on file
Joseph Nguyen, DO	Dr. Nguyen has nothing to disclose.
Kristel Sleegers	No disclosure on file
Norman Ajiboye, MD, FAAN	Dr. Ajiboye has nothing to disclose.
Christine Van Broeckhoven, PhD	Dr. Van Broeckhoven has nothing to disclose.
Barbara Borroni, MD	Dr. Borroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Borroni has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
James C. Cloyd, PharmD	No disclosure on file
Fawzi Babtain, MD	Dr. Babtain has nothing to disclose.
Allison Wright Willis, MD	Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Pharmacoepidemiology and Drug Safety. Dr. Wright Willis has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. The institution of Dr. Wright Willis has received research support from NIH. The institution of Dr. Wright Willis has received research support from NIA. The institution of Dr. Wright Willis has received research support from Biogen. The institution of Dr. Wright Willis has received research support from Parkinson Foundation. The institution of Dr. Wright Willis has received research support from Arcadia.
Gordon Mazibrada, MD	No disclosure on file
Joo Yeon Nam, MD	No disclosure on file
Mar Carreno, MD	No disclosure on file
Todd Grinnell, PhD	Todd Grinnell, PhD has received personal compensation for serving as an employee of Sunovion Pharmaceuticals Inc..
George Lai, MD	No disclosure on file
Erica Selheimer, MD	No disclosure on file
Junaid H. Siddiqui, MD	Dr. Siddiqui has nothing to disclose.
Eric T. Wong, MD, FAAN	Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ZaiLab. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Turning Point Therapeutics. Dr. Wong has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Imvax. The institution of Dr. Wong has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novocure. The institution of Dr. Wong has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Turning Point Therapeutics. The institution of Dr. Wong has received research support from Novocure. Dr. Wong has received intellectual property interests from a discovery or technology relating to health care. Dr. Wong has received publishing royalties from a publication relating to health care.
Kazuko Matsuda, MD	No disclosure on file
Ayaz M. Khawaja, MD	Dr. Khawaja has nothing to disclose.
Nikita Dedhia, MD	No disclosure on file
Juebin Huang, MD, PhD	Dr. Huang has nothing to disclose.
Nicholas Schwab	The institution of Nicholas Schwab has received research support from Biogen. The institution of Nicholas Schwab has received research support from Roche.
Alok Sachdeva, MD	No disclosure on file
Nadeem I. Khan, MD	Dr. Khan has nothing to disclose.
Natasa Dragicevic, MD, PhD	No disclosure on file
Samuel J. Cohn, MD	No disclosure on file
Marieke C. J. Dekker	No disclosure on file
Jackie Durfee	No disclosure on file
Courtney E. McIlduff, MD	The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Veronique Bourg	No disclosure on file
Jesper Hagemeier	No disclosure on file
Marissa Kellogg, MD, MPH, FAAN	The institution of Dr. Kellogg has received research support from VA & DoD.
Nancy Wang, MD	The institution of Dr. Wang has received research support from Merck. Dr. Wang has received publishing royalties from a publication relating to health care.
Jordan J. Elm	The institution of Dr. Elm has received research support from NIH.
Anthony Feinstein, MD	Anthony Feinstein, MD has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis, Biogen, Roche and Sanofi-Genzyme. The institution of Anthony Feinstein, MD has received research support from Multiple Sclerosis Society of Canada. Anthony Feinstein, MD has received publishing royalties from a publication relating to health care.
William K. Jens, DO, FAAN	Dr. Jens has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abvie.
Jeffrey B. Hainsworth, DO	Dr. Hainsworth has stock in Amgen Inc. Dr. Hainsworth has stock in Bristol Myers Squibb Company. Dr. Hainsworth has stock in Johnson & Johnson. Dr. Hainsworth has stock in Medtronic PLC. Dr. Hainsworth has stock in Merck. Dr. Hainsworth has stock in Stryker Corp. Dr. Hainsworth has stock in ABBV.
Muhammad Ibrahimi, MD	No disclosure on file
Aiesha Ahmed, MD, MBA, FAAN	Dr. Ahmed has stock in Doximity.
Paula Rauschkolb, DO	No disclosure on file
Oluwadamilola O. Ojo, MD	Dr. Ojo has nothing to disclose.
Kunal V. Desai, MD	Dr. Desai has nothing to disclose.
Sarah Gheuens, MD	No disclosure on file
Kaye E. Sedarsky, MD	Dr. Sedarsky has nothing to disclose.
Jeffrey Ralph, MD	No disclosure on file
Hannah Breit, MD	Dr. Breit has nothing to disclose.
Daniel B. Rubin, MD, PhD	No disclosure on file
Bradley Molyneaux, MD, PhD	Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Molyneaux has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Billing, Cochran, Lyles, Mauro and Ramsey. The institution of Dr. Molyneaux has received research support from NIH. Dr. Molyneaux has received publishing royalties from a publication relating to health care.
MARIA JOSE MORENO JIMENEZ	No disclosure on file
Hajere Gatollari	No disclosure on file
Francisco Javier Ricart	Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
W. T. Kimberly, MD, PhD	Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astrocyte Pharmaceuticals. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acasti Pharma. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Kimberly has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Kimberly has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics. Dr. Kimberly has stock in Woolsey Pharmaceuticals. Dr. Kimberly has stock in Acasti Pharma. The institution of Dr. Kimberly has received research support from NIH. The institution of Dr. Kimberly has received research support from Hyperfine, Inc.. The institution of Dr. Kimberly has received research support from Alzheimer's Association. Dr. Kimberly has received intellectual property interests from a discovery or technology relating to health care.
Mary E. Richert	No disclosure on file
Jennie Medin	No disclosure on file
Clotilde Hainline, MD	Dr. Hainline has nothing to disclose.
Letizia G. Borges, MD	No disclosure on file
Evan R. Schloss, MD	Dr. Schloss has nothing to disclose.
Muhammad Ubaid Hafeez, MD	Dr. Hafeez has nothing to disclose.
Ali Ezzati, MD	The institution of Dr. Ezzati has received research support from NIA. The institution of Dr. Ezzati has received research support from Alzheimer's Association. The institution of Dr. Ezzati has received research support from Cure Alzheimer's Fund.
Kristin Halvorsen	No disclosure on file
Patrizia Casaccia, MD, PhD	No disclosure on file
Kevin N. Ramdas, MD	No disclosure on file
Luis Guada-Delgado, MD	Dr. Guada-Delgado has nothing to disclose.
Erica Marini	No disclosure on file
Ka-Ho Wong	The institution of Mr. Wong has received research support from The Sumaira Foundation . The institution of Mr. Wong has received research support from The Siegel Rare Neuroimmune Association.
Juan Fortea, MD, PhD	Dr. Fortea has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AC Inmune. Dr. Fortea has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Fortea has received research support from NIH. Dr. Fortea has received intellectual property interests from a discovery or technology relating to health care.
Anand Venkatraman, MBBS	No disclosure on file
Roomana Ahad	No disclosure on file
Amanda S. Lindy, PhD	Dr. Lindy has received personal compensation for serving as an employee of GeneDx.
Farid U. Din, MD	No disclosure on file
Rozina Wadhwania, MD	No disclosure on file
James Burge	No disclosure on file
Lucinda L. Hugos, PT	Ms. Hugos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GW Pharmaceuticals. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Evidera, Inc.. Ms. Hugos has received personal compensation in the range of $0-$499 for serving as a Consultant for Techspert.io Ltd.. Ms. Hugos has received research support from Portland VA. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received research support from Oregon Health & Science University. Ms. Hugos has received publishing royalties from a publication relating to health care.
Riccardo Manca, Msc	No disclosure on file
Vishakhadatta Mathur Kumaraswamy, MD	The institution of Dr. Mathur Kumaraswamy has received research support from Woolsey Pharmaceuticals.
Carrie M. Hersh, DO, MSc, FAAN	Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech_GN41791. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol-Myers Squibb . Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Hersh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Hersh has received research support from Biogen. The institution of Dr. Hersh has received research support from Novartis. The institution of Dr. Hersh has received research support from Genentech_GN41791. The institution of Dr. Hersh has received research support from PCORI. The institution of Dr. Hersh has received research support from Bristol Myers Squibb.
Dianalee McKnight, PhD	Dr. McKnight has nothing to disclose.
Celia Oreja Guevara	Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving as a Consultant for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for merck. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for roche. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for sanofi. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for novartis. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for viatris. Celia Oreja Guevara has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for biogen. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for bms. Celia Oreja Guevara has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for jannsen.
Pankaj Sharma, MD	Dr. Sharma has nothing to disclose.
Vismay J. Thakkar, MD	Dr. Thakkar has nothing to disclose.
Bing Zhu, MD	No disclosure on file
Takayuki Kondo, MD, PhD	Prof. Kondo has nothing to disclose.
Andrew Michalak, MD	No disclosure on file
Zachary Kennedy	No disclosure on file
Eliza C. Miller, MD	Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical malpractice cases. The institution of Dr. Miller has received research support from National Institutes of Health. Dr. Miller has a non-compensated relationship as a member of ASA Advisory Council with American Heart Association/American Stroke Association that is relevant to AAN interests or activities.
Debora B. Angst, MD	No disclosure on file
Clement Francois	No disclosure on file
Joshua J. Martin, MD	No disclosure on file
Andreas Schulte-Mecklenbeck	Andreas Schulte-Mecklenbeck has nothing to disclose.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Charlene J. Ong, MD	Dr. Ong has nothing to disclose.
Mohanned Alhamrani	No disclosure on file
Jiri G. Safar, MD	No disclosure on file
Dwain Tolbert, PhD	No disclosure on file
Matthew D. Holtkamp, DO	Dr. Holtkamp has nothing to disclose.
Douglas C. McAdams, MD	Dr. McAdams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Space Nuclear Power Corporation.
Andres Barboza, MD, PhD	No disclosure on file
Nina H. Kim, MD	Dr. Kim has nothing to disclose.
Cherie Herren, MD	Dr. Herren has nothing to disclose.
Matthew D. Cykowski, MD	No disclosure on file
Howard A. Rowley, MD, FAAN	No disclosure on file
Asya I. Wallach, MD	Dr. Wallach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech. Dr. Wallach has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen.
David M. Dawson, MD, FAAN	No disclosure on file
Ilana B. Katz Sand, MD	The institution of Dr. Katz Sand has received research support from National Multiple Sclerosis Society. The institution of Dr. Katz Sand has received research support from Hirschl Foundation. The institution of Dr. Katz Sand has received research support from National Institutes of Health. Dr. Katz Sand has received personal compensation in the range of $500-$4,999 for serving as a Conference presenter with ��ɫ��.
Sara E. Berman, MD, PhD	Dr. Berman has received personal compensation in the range of $0-$499 for serving as a Consultant for Recursive.
David Valentine, MD	No disclosure on file
Allison Fryman	Allison Fryman has nothing to disclose.
Robin D'Ambrosio	No disclosure on file
Jennifer M. Taylor, MBBS	No disclosure on file
Shweta Sapnar, MD	No disclosure on file
Anusha Edara, MD	No disclosure on file
Dylan Sperling	No disclosure on file
Kristin Stacy, C-TAGME	No disclosure on file
Louis S. Russo, Jr., MD, FAAN	No disclosure on file
Jenie George, MD	No disclosure on file
Flavia L. Lee, DO	No disclosure on file
Abdullah Alshammaa, MD	Dr. Alshammaa has nothing to disclose.
Duncan P. Smyth, MD	No disclosure on file
Justin V. Abraham, MD	Dr. Abraham has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biohaven Pharmaceutical.
Ahmad Al-Awwad, MD	Dr. Al-Awwad has nothing to disclose.
Dilip Kumar Jayaraman, MD	Dr. Jayaraman has nothing to disclose.
Eloise Watson, MBChB, FRACP	No disclosure on file
Deepak K. Gupta, MBBS	The institution of Dr. Gupta has received research support from Department of Defense.
Danielle M. Stember, MD	Dr. Stember has nothing to disclose.
Hitoshi Mori, MD	No disclosure on file
Jody Manners, MD, FAAN	Dr. Manners has nothing to disclose.
David R. Baker	No disclosure on file
Daniel S. Harrison, MD	Dr. Harrison has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Glass Health. Dr. Harrison has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Diedrich & Donohue, LLP.
Ken Cheung	Ken Cheung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Tsumura.
Gordon Sze	Gordon Sze has nothing to disclose.
James Fryer	James Fryer has received intellectual property interests from a discovery or technology relating to health care.
Imran Farooqui, MD	No disclosure on file
Sandhya Mehla, MD	Dr. Mehla has received publishing royalties from a publication relating to health care.
Angelica M. Lee, DO	Dr. Lee has nothing to disclose.
Muhammad Ahmed, MD	Dr. Ahmed has nothing to disclose.
Nuala McNicholas, MBBS	Dr. McNicholas has nothing to disclose.
Luke F. O'Donnell, MD	No disclosure on file
Jan Leonard	No disclosure on file
Harrison J. Brown	No disclosure on file
Jenelle Feather	No disclosure on file
Harmanpreet Tiwana, MD	No disclosure on file
Estrella Gomez-Tortosa, MD	No disclosure on file
Clarence Li, MD	No disclosure on file
Micaela Mitolo, PhD	No disclosure on file
Abderrahim Mzahem	No disclosure on file
Fernando J. Gracia, MD	No disclosure on file
Barbara M. Carvalho	Miss Carvalho has nothing to disclose.
Mellanie V. Springer, MD	The institution of Dr. Springer has received research support from National Institutes of Health.
Takeshi Nakajima	No disclosure on file
Oriol Grau, MD	No disclosure on file
Isabel Santana	No disclosure on file
Peter Zhang	No disclosure on file
Ninad Desai, MBBS	Dr. Desai has nothing to disclose.
Maranatha Ayodele, MD	Dr. Ayodele has nothing to disclose.
Ian R. Woodcock, MBBS	The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Dr. Woodcock has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Biosciences. The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Souffle. The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Keros Therapeutics. The institution of Dr. Woodcock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Juvena Therapeutics. Dr. Woodcock has received research support from NIH.
Imran Ahmed, MD	No disclosure on file
Irene M. Tracey	No disclosure on file
Anirudh Sreekrishnan	Dr. Sreekrishnan has nothing to disclose.
M. Catarina Silva, PhD	No disclosure on file
Maria Rosario G. Almeida, MD	No disclosure on file
Kate W. Hocquard, MD	No disclosure on file
Gary Zirpoli, PhD	No disclosure on file
Serena Yin, MD	Dr. Yin has nothing to disclose.
Grace M. Tabatabai, MD	Dr. Tabatabai has nothing to disclose.
Michal Greenberg-Abrahami	No disclosure on file
Maria G. Martucci, MD	Dr. Martucci has nothing to disclose.
N. Paul Rosman, MD, FAAN	No disclosure on file
Maxine Koepp	Ms. Koepp has nothing to disclose.
Sathiji Kathiresu Nageshwaran, PhD	No disclosure on file
Helena Gama	Helena Gama has received personal compensation for serving as an employee of Bial-Portela & Cª S.A..
Amaal J. Starling, MD, FAAN	Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Starling has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Miller Medical. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Salvia. Dr. Starling has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbvie. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Starling has received personal compensation in the range of $500-$4,999 for serving as a Consultant for eNeura. Dr. Starling has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Woodberry Associates .
Jose Meca Lallana, MD	Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol-Myers-Squibb. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Meca Lallana has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. The institution of Dr. Meca Lallana has received research support from Merck. The institution of Dr. Meca Lallana has received research support from Novartis. The institution of Dr. Meca Lallana has received research support from Roche. The institution of Dr. Meca Lallana has received research support from Sanofi. The institution of Dr. Meca Lallana has received research support from Biogen.
Sonya E. Zhou, MD	Sonya Zhou has nothing to disclose.
Jenny J. Feng, MD	Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Feng has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon.
Siddharthan Chandran	No disclosure on file
Bonnie Wong, MD, MPH	Dr. Wong has nothing to disclose.
Emily Zucker	No disclosure on file
Teresa Ayuso, MD	No disclosure on file
David Titelbaum, MD	No disclosure on file
David G. Coughlin, MD	Dr. Coughlin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for M3 Global Research. The institution of Dr. Coughlin has received research support from ��ɫ��. The institution of Dr. Coughlin has received research support from NIA. The institution of Dr. Coughlin has received research support from NINDS.
Neha Patel, MD	No disclosure on file
Annie Racine, PhD	Annie Racine has received personal compensation for serving as an employee of Biogen. Annie Racine has received stock or an ownership interest from Biogen.
Angelika Erwin	Angelika Erwin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Angelika Erwin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
Deborah Horenstein, MD	No disclosure on file
Ruth Leadbetter, FRACP	No disclosure on file
Christopher Elder, MD	Dr. Elder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SK Life Science Inc.. Dr. Elder has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Science Inc.. Dr. Elder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Current Neurology and Neuroscience Reports.
Mary E. Shenk	No disclosure on file
Rina I. Falb, PhD	Dr. Falb has nothing to disclose.
Hea Ree Park	Hea Ree Park has nothing to disclose.
Kanako Namekawa, MD	No disclosure on file
Erin R. Kulick, PhD	No disclosure on file
Stuart J. McCarter, MD	The institution of Dr. McCarter has received research support from NIH. The institution of Dr. McCarter has received research support from American Academy of Sleep Medicine Foundation.
Anh-Thu N. Vu, MD, MS	Dr. Vu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ScholarRx.
James F. Castellano, MD, PhD	Dr. Castellano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neuro One medical technologies. The institution of Dr. Castellano has received research support from NIH. The institution of Dr. Castellano has received research support from University of Pittsburgh.
UFUK EMRE	No disclosure on file
Geoffrey J. McKendry	No disclosure on file
Matthew T. McCarthy, MD	No disclosure on file
Dana Coleman	No disclosure on file
Robin P. Miller	No disclosure on file
Tobi Van den Bossche	No disclosure on file
M B. Sundaram, FRCPC, FAAN	No disclosure on file
Shashank Shekhar, MBBS	The institution of Dr. Shekhar has received research support from Sponsor Department of Health and Human Services. The institution of Dr. Shekhar has received research support from PockitDx.
Jang Yun	No disclosure on file
Nicholas E. Peterson	No disclosure on file
Julia N. Bucklan, DO	Dr. Bucklan has nothing to disclose.
Jason H. Lin, MD	No disclosure on file
Jalyoung Joe, MD	Dr. Joe has nothing to disclose.
Charles E. Kamen, MD	No disclosure on file
Achillefs Ntranos, MD	No disclosure on file
Siew Mei Yap, MBBS	Dr. Yap has received research support from Novartis.
Sangeetha Poongunam Isaac	Sangeetha Poongunam Isaac has stock in Pfizer.
Julia Klein, NP	An immediate family member of Ms. Klein has received personal compensation for serving as an employee of Amgen. An immediate family member of Ms. Klein has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen.
Kelianne Cummings	No disclosure on file
Davena Zhang, MD	No disclosure on file
Jamie L. Palaganas, MD, FAAN	Dr. Palaganas has nothing to disclose.
John Boscardin	No disclosure on file
Steven Kymes	Steven Kymes has received personal compensation for serving as an employee of Lundbeck. Steven Kymes has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Journal of Ophthalmology. Steven Kymes has received research support from Emmes Corporation.
Audrey Leasure	Ms. Leasure has nothing to disclose.
Ayushi Chauhan	No disclosure on file
Andrea R. Zammit, PhD	Dr. Zammit has nothing to disclose.
Kaitlin M. Snyder	No disclosure on file
Rula Hajj-Ali, MD	Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Rula Hajj-Ali, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zena. Rula Hajj-Ali, MD has received publishing royalties from a publication relating to health care.
Anup D. Patel, MD, FAAN	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with AAN that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to AAN interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with AAN Institute that is relevant to AAN interests or activities.
Akio Kimura, MD	Dr. Kimura has nothing to disclose.
Ryan Hubbard, MD	No disclosure on file
Tanya N. Turan, MD, FAAN	Dr. Turan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer/Merck. Dr. Turan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Gore Inc. Dr. Turan has received publishing royalties from a publication relating to health care. Dr. Turan has received publishing royalties from a publication relating to health care.
Ria Pal, MD	Dr. Pal has nothing to disclose.
Eric Mariuma, MD	Dr. Mariuma has nothing to disclose.
Paul M. George, MD, PhD, MSE, FAAN	Dr. George has received personal compensation in the range of $0-$499 for serving as a Consultant for ConductiveBio. Dr. George has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law firms. The institution of Dr. George has received research support from Conductive Bio. The institution of Dr. George has received research support from NIH. Dr. George has received intellectual property interests from a discovery or technology relating to health care. Dr. George has received personal compensation in the range of $10,000-$49,999 for serving as a Adjudicator with Baim Insititute. Dr. George has a non-compensated relationship as a Board Member with ��ɫ�� that is relevant to AAN interests or activities. Dr. George has a non-compensated relationship as a International Stroke Council Program committee member with American Heart Association that is relevant to AAN interests or activities.
Bandar Nasser A Aljafen, MD, FAAN	No disclosure on file
Yohei Harada, MD	Dr. Harada has nothing to disclose.
Sushma Bellamkonda, MD	No disclosure on file
Durdane Aksoy, MD	No disclosure on file
Ethan Murphy	No disclosure on file
James P. Wymer, MD, PhD, FAAN	No disclosure on file
Hisashi Okada, MD, PhD	No disclosure on file
Yasmin Aghajan, MD	Dr. Aghajan has nothing to disclose.
Keerthivaas Premkumar	No disclosure on file
Jonathan Falsetta, PharmD	No disclosure on file
Pieter Janssen	No disclosure on file
Yasuhiro Suzuki, MD, PhD	No disclosure on file
Alex Exuzides	Alex Exuzides has nothing to disclose.
Erin Furr-Stimming, MD, FAAN	Dr. Furr-Stimming has received personal compensation for serving as an employee of Help4HD International. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedPage. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Life Sciences. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Latus Bio. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Atalanta Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SkyHawk Therapeutics. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atalanta Therapeutics. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine Bioscienes. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. The institution of Dr. Furr-Stimming has received research support from Sage Therapeutics. The institution of Dr. Furr-Stimming has received research support from HDSA. The institution of Dr. Furr-Stimming has received research support from Prilennia. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care. Dr. Furr-Stimming has a non-compensated relationship as a Committee member with AAN UES Committee that is relevant to AAN interests or activities.
Faddi G. Saleh Velez, MD	Dr. Saleh Velez has nothing to disclose.
Yngve Hallstrom	No disclosure on file
Hiba Fakhri, MD	Ms. Fakhri has nothing to disclose.
Rosa Yu	No disclosure on file
Sean Evans, MD	No disclosure on file
Christine M. Doherty	Ms. Doherty has received research support from ��ɫ��.
Andrew Christiana, MD	Dr. Christiana has nothing to disclose.
Ibrahim Migdady, MD	Dr. Migdady has nothing to disclose.
Jaime Raymond	Jaime Raymond has nothing to disclose.
Francisco Ponce	No disclosure on file
Fatemeh Hajighasemi, MD	No disclosure on file
Asri Yuliati, MD	No disclosure on file
Umar Shariff, MD	No disclosure on file
Lindsay K. Blair, MSN	Ms. Blair has nothing to disclose.
Majed A. Alomar, MBBS	Dr. Alomar has nothing to disclose.
Ossama Khazaal, MD	No disclosure on file
Mark E. Pierce, MD	Dr. Pierce has nothing to disclose.
Pete Schmidt	No disclosure on file
Brent L. Fogel, MD, PhD, FAAN	Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for National Ataxia Foundation. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Ataxia Global Initiative. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Today. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Genetics. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Genes. Dr. Fogel has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neuromarkers. The institution of Dr. Fogel has received research support from the National Institutes of Health. The institution of Dr. Fogel has received research support from the National Ataxia Foundation. The institution of an immediate family member of Dr. Fogel has received research support from the National Institutes of Health, the National Science Foundation, and the Department of Defense. The institution of Dr. Fogel has received research support from US Department of Defense .
Sarah M. Tisel, MD	No disclosure on file
Riwanti Estiasari	No disclosure on file
Aleksej Zuzek, PhD	Dr. Zuzek has received personal compensation for serving as an employee of AbbVie Inc.. Dr. Zuzek has stock in AbbVie Inc..
Nawaf M. Abohamra, MBBS	No disclosure on file
Alexandra Galati, MD	No disclosure on file
Mohammed Alanazy, MD	Dr. Alanazy has nothing to disclose.
Steven L. Meyers, MD	No disclosure on file
Christine M. Boutwell, MD	Dr. Boutwell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Boutwell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. Boutwell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Boutwell has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva Neuroscience. Dr. Boutwell has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genzyme. The institution of Dr. Boutwell has received research support from Biogen. The institution of Dr. Boutwell has received research support from Adamas.
Erez Nossek	No disclosure on file
Steven Trau, MD	Dr. Trau has nothing to disclose.
Waleed Ahmed Khoja, MD	Dr. Khoja has nothing to disclose.
Kyle T. Mitchell, MD	Dr. Mitchell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Mitchell has received research support from Medtronic. The institution of Dr. Mitchell has received research support from Deep Brain Innovations. The institution of Dr. Mitchell has received research support from National Institutes of Health. The institution of Dr. Mitchell has received research support from National Institute on Aging.
Moath Hamed, MD	Dr. Hamed has nothing to disclose.
Eva-Laudon Meyer	No disclosure on file
Lenka Hvizdosova	No disclosure on file
Samuel Giles, MD	The institution of Dr. Giles has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai . Dr. Giles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai . Dr. Giles has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli lilly .
Kelly G. Gwathmey, MD	Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Strongbridge. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Gwathmey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cabaletta. Dr. Gwathmey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals.
Gilbert A. Block, MD, PhD	No disclosure on file
Evan Rosenberg, MD, PhD	No disclosure on file
David Rahimian, MD	No disclosure on file
Amanda Sandoval Karamian, MD	The institution of Dr. Sandoval Karamian has received research support from Pediatric Epilepsy Research Foundation.
Robert Chong, MD	No disclosure on file
Amanda Persaud, MD	Dr. Persaud has nothing to disclose.
D Kevin Horton	No disclosure on file
Olivia Gardner, MD, PhD	No disclosure on file
Tsubasa Yuki	No disclosure on file
Belinda Yew	Ms. Yew has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��